Carli, M.; Vaglini, F.; Risaliti, E.; Citi, G.; Masini, M.; Kolachalam, S.; Maggio, R.; Corsini, G.U.; Novelli, M.; De Tata, V.;
et al. β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA). Pharmaceuticals 2021, 14, 767.
https://doi.org/10.3390/ph14080767
AMA Style
Carli M, Vaglini F, Risaliti E, Citi G, Masini M, Kolachalam S, Maggio R, Corsini GU, Novelli M, De Tata V,
et al. β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA). Pharmaceuticals. 2021; 14(8):767.
https://doi.org/10.3390/ph14080767
Chicago/Turabian Style
Carli, Marco, Francesca Vaglini, Eleonora Risaliti, Gianluca Citi, Matilde Masini, Shivakumar Kolachalam, Roberto Maggio, Giovanni Umberto Corsini, Michela Novelli, Vincenzo De Tata,
and et al. 2021. "β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA)" Pharmaceuticals 14, no. 8: 767.
https://doi.org/10.3390/ph14080767
APA Style
Carli, M., Vaglini, F., Risaliti, E., Citi, G., Masini, M., Kolachalam, S., Maggio, R., Corsini, G. U., Novelli, M., De Tata, V., & Scarselli, M.
(2021). β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA). Pharmaceuticals, 14(8), 767.
https://doi.org/10.3390/ph14080767
